デジタル治療のの世界市場2017-2027

◆英語タイトル:THE DIGITAL THERAPEUTICS MARKET FORECAST 2017-2027 : Forecasts by Application (Diabetes, Obesity CVD, CNS, Respiratory) End-User, (Patients, Caregivers, Employers, Payers, Pharmaceutical Companies) and Geography
◆商品コード:VGAIN712057
◆発行会社(リサーチ会社):visiongain
◆発行日:2017年11月
◆ページ数:234
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Sigle User(1名閲覧)GBP2,499 ⇒換算¥374,850見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥449,850見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥749,850見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。

visiongain社が発行した当調査レポートでは、デジタル治療のの世界市場について調査・分析し、デジタル治療のの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
・レポートの概要
・イントロダクション
・デジタル治療のの世界市場
 (市場規模予測、市場動向、市場の成長要因・阻害要因など)
・デジタル治療のの世界市場:セグメント別市場分析
・デジタル治療のの世界市場:地域別市場分析、市場規模予測
・市場環境分析
・専門家の見解
・主要企業分析
・結論
【レポートの概要】

Digital Therapeutics – our new study reveals trends, R&D progress, and predicted revenues
Where is the Digital Therapeutics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 234-page report provides 206 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Digital Therapeutics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 6 Digital Therapeutics Applications and 5 End Users in the report at a global and regional level:

Global Digital Therapeutics Market by Application
• Obesity
• Diabetes
• CNS
• CVD
• Respiratory
• Other

Global Digital Therapeutics Market by End User
• Patients
• Payers
• Caregivers
• Employers
• Pharmaceutical Companies

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 major regional and 21 major national markets:

• North America:
• The US
• Canada

• Latin America:
• Brazil
• Mexico
• Rest of Latin America

• Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Russia
• Rest of Europe

• Asia-Pacific:
• China
• India
• Japan
• ASEAN
• Australia and New Zealand
• South Korea
• Rest of Asia-Pacific

• Middle East:
• GCC Countries
• Israel

• Africa:
• South Africa
• Central Africa
• North Africa

The report also includes profiles and for some of the leading companies in the Digital Therapeutics market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, the US, the UK and the APAC region in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Digital Therapeutics will surpass $1.3bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Digital Therapeutics Market report helps you
In summary, our 234-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the Digital Therapeutics market, with forecasts for 6 applications and 5 end-users across 6 key regional markets as well as forecasts for 21 major national markets – See forecasts for the Digital Therapeutics market in North America, Latin America, Europe, Asia-Pacific, the Middle East and Africa, as well as the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Russia, Japan, China, India, Australia and New Zealand, ASEAN countries, South Korea, GCC Countries, Israel and South Africa, Central Africa and North Africa
• What stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for some of the major companies involved in the Digital Therapeutics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Digital Therapeutics market and leading companies. You will find data, trends and predictions.

Get our report today The Digital Therapeutics Market Forecast 2017-2027: Forecasts by Application (Diabetes, Obesity CVD, CNS, Respiratory) End-User, (Patients, Caregivers, Employers, Payers, Pharmaceutical Companies) and Geography.

【レポートの目次】

1. Report Overview
1.1. Global Digital Therapeutics Market Overview
1.2. Why You Should Read This Report
1.3. How This Report Delivers
1.4. Key Questions Answered by This Analytical Report Include:
1.5. Who is This Report For?
1.6. Methodology
1.6.1. Primary Research
1.6.2. Secondary Research
1.6.3. Market Evaluation &Forecasting Methodology
1.7. Frequently Asked Questions (FAQ)
1.8. Associated Visiongain Reports
1.9. About Visiongain
1.10. Introduction to the Digital Therapeutics Market
1.11. Digital Therapeutics Market Structure
1.12. Digital Therapeutics Market Definition
1.13. Digital Therapeutics Market Application Category Submarkets Definition
1.13.1. Digital Therapeutics Diabetes Submarket Definition
1.13.2. Digital Therapeutics Obesity Submarket Definition
1.13.3. Digital Therapeutics Market Cardiovascular Disease Submarket Definition
1.14. Digital Therapeutics Market Taxonomy

2. Global Digital Therapeutics Market Snapshot
2.1. Global Digital Therapeutics Market Dynamics
2.2. Global Digital Therapeutics Market: Drivers
2.2.1. Demographic Shift
2.2.2. Rising Incidence of Chronic Disorders
2.2.3. Technological Advancements
2.2.4. Increased Venture Funding for Start-up
2.2.5. Rising Healthcare Cost
2.2.6. Rise in Smartphone Consumption
2.2.7. Government Initiatives
2.2.8. Patient Awareness for Better Products
2.3. Global Digital Therapeutics Market: Restraints
2.3.1. High Cost and Less Adoption in Emerging Countries
2.4. Global Digital Therapeutics Market: Trends
2.4.1. Technology
2.4.2. Government Regulations
2.4.3. Rise in Medical Spending
2.5. Global Digital Therapeutics Market: Opportunities
2.5.1. Tele-health
2.5.2. Analytics
2.6. Global Digital Therapeutics Market: Porter’s Five Forces Model
2.6.1. Substitute Services and Products
2.6.2. Buyer Power
2.6.3. Power of Supplier
2.6.4. Existing Rivalry
2.6.5. New Entrants

3. Global Digital Therapeutics Market, By Application, 2017-2027
3.1. Introduction
3.2. Global Digital Therapeutics Market Size and Forecast, By Application
3.2.1. Diabetes Segment
3.2.2. Obesity Segment
3.2.3. CVD Segment
3.2.4. CNS Segment
3.2.5. Respiratory Segment
3.2.6. Others Segment
3.3. Global Digital Therapeutics Market Attractiveness Index, By Application

4. Global Digital Therapeutics Market, By End-User, 2017-2027
4.1. Introduction
4.2. Global Digital Therapeutics Market Size and Forecast, By End-User
4.2.1. Patients Segment
4.2.2. Caregivers Segment
4.2.3. Employers Segment
4.2.4. Payers Segment
4.2.5. Pharmaceutical Companies Segment
4.3. Global Digital Therapeutics Market Attractiveness Index, By End-User
4.4. Introduction
4.5. Global Digital Therapeutics Market Size and Forecast, By Region
4.5.1. North America
4.5.2. Latin America
4.5.3. Europe
4.5.4. Asia Pacific
4.5.5. Middle East
4.5.6. Africa
4.6. Global Digital Therapeutics Market Attractiveness Index, By Region
4.7. Leading Digital Therapeutics Market, Forecast 2017-2027, By Region

5. North America Digital Therapeutics Market Analysis and Forecast, 2017-2027
5.1. Introduction
5.1.1. North America
5.2. North America Digital Therapeutics Market Forecast, By Country, 2017-2027
5.2.1. U.S.
5.2.2. Canada
5.3. North America Medical Equipment Market, By Application
5.4. North America Medical Equipment Market, By End-User
5.5. North America Digital Therapeutics Market Attractiveness Index
5.5.1. By Application
5.5.2. By End-User
5.5.3. By Country

6. Latin America Digital Therapeutics Market Analysis and Forecast, 2017-2027
6.1. Introduction
6.1.1. Latin America
6.2. Latin America Digital Therapeutics Market Forecast, By Country, 2017-2027
6.2.1. Brazil
6.2.2. Mexico
6.2.3. Rest of Latin America
6.3. Latin America Medical Equipment Market, By Application
6.4. Latin America Medical Equipment Market, By End-User
6.5. Latin America Digital Therapeutics Market Attractiveness Index
6.5.1. By Application
6.5.2. By End-User
6.5.3. By Country

7. Europe Digital Therapeutics Market Analysis and Forecast, 2017-2027
7.1. Introduction
7.2. Europe Digital Therapeutics Market Forecast, By Country, 2017-2027
7.2.1. U.K.
7.2.2. France
7.2.3. Germany
7.2.4. Italy
7.2.5. Spain
7.2.6. Russia
7.2.7. Rest of Europe
7.3. Europe Medical Equipment Market, By Application
7.4. Europe Medical Equipment Market, By End-User
7.5. Europe Digital Therapeutics Market Attractiveness Index
7.5.1. By Application
7.5.2. By End-User
7.5.3. By Country

8. Asia Pacific Digital Therapeutics Market Analysis and Forecast, 2017-2027
8.1. Introduction
8.2. Asia Pacific Digital Therapeutics Market Forecast, By Country, 2017-2027
8.2.1. China
8.2.2. India
8.2.3. Australia and New Zealand
8.2.4. Japan
8.2.5. ASEAN
8.2.6. South Korea
8.2.7. Rest of Asia Pacific
8.3. Asia Pacific Medical Equipment Market, By Application
8.4. Asia Pacific Medical Equipment Market, By End-User
8.5. Asia Pacific Digital Therapeutics Market Attractiveness Index
8.5.1. By Application
8.5.2. By End-User
8.5.3. By Country

9. Middle East Therapeutics Market Analysis and Forecast, 2017-2027
9.1. Introduction
9.2. Middle East Digital Therapeutics Market Forecast, By Country, 2017-2027
9.2.1. GCC Countries
9.2.2. Israel
9.3. Middle East Medical Equipment Market, By Application
9.4. Middle East Medical Equipment Market, By End-User
9.5. Middle East Digital Therapeutics Market Attractiveness Index
9.5.1. By Application
9.5.2. By End-User
9.5.3. By Country

10. Africa Therapeutics Market Analysis and Forecast, 2017-2027
10.1. Introduction
10.2. Africa Digital Therapeutics Market Forecast, By Country, 2017-2027
10.2.1. South Africa
10.2.2. Central Africa
10.2.3. North Africa
10.3. Africa Medical Equipment Market, By Application
10.4. Africa Medical Equipment Market, By End-User
10.5. Africa Digital Therapeutics Market Attractiveness Index
10.5.1. By Application
10.5.2. By End-User
10.5.3. By Country

11. Company Profiles
11.1. Omada Health
11.1.1. Company Overview
11.1.2. Key Developments
11.2. Canary Health
11.2.1. Company Overview
11.2.2. Key Developments
11.3. Noom Inc.
11.3.1. Company Overview
11.3.2. Key Developments
11.4. Livongo Health
11.4.1. Company Overview
11.4.2. Key Developments
11.5. WellDoc Inc.
11.5.1. Company Overview
11.5.2. Key Developments
11.6. Propeller Health
11.6.1. Company Overview
11.6.2. Key Developments
11.7. Evolent Health
11.7.1. Company Overview
11.8. Doximity
11.8.1. Doximity Company Overview
11.8.2. Key Developments
11.9. Perfint Healthcare
11.9.1. Company Overview
11.10. Proteus Digital Health Inc.
11.10.1. Company Overview
11.11. Other Companies of Interest in the Digital Therapeutics Market

12. Conclusion

13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form

List of Figures
Figure 1.1 Global Digital Therapeutics Market Segmentation Overview
Figure 1.2 Global Digital Therapeutics Market Forecast
Figure 2.1: Global Digital Therapeutics Market Forecast Value (US$ Bn) Forecast and AGR%, 2016-2027
Figure 2.2 Global Digital Therapeutics Market Porter’s Five Forces Model
Figure 3.1 Global Digital Therapeutics Market, By Application, AGR Forecast 2017-2027 (AGR %)
Figure 3.2 Global Digital Therapeutics Market, By Application Segment Forecast 2017-2027 (US$Bn, Global AGR %)
Figure 3.3: Global Digital Therapeutics Market, Market Share Split & BPS Analysis, By Application, 2017–2027
Figure 3.4 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Diabetes Segment, 2016–2027
Figure 3.5 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Obesity, 2016–2027
Figure 3.6 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By CVD, 2016–2027
Figure 3.7 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By CNS, 2016–2027
Figure 3.8 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Respiratory, 2016–2027
Figure 3.9 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Others, 2016–2027
Figure 3.10 Global Digital Therapeutics Market Attractiveness Index, By Application, 2017–2027
Figure 4.1 Global Digital Therapeutics Market, By End-User, AGR Forecast 2017-2027 (AGR %)
Figure 4.2 Global Digital Therapeutics Market, By End-User Segment Forecast 2017-2027 (US$Bn, Global AGR %)
Figure 4.3: Global Digital Therapeutics Market, Market Share Split & BPS Analysis, By End-User Segment, 2017–2027
Figure 4.4 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Patients Segment, 2016–2027
Figure 4.5 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Caregivers Segment, 2016–2027
Figure 4.6 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Employers Segment, 2016–2027
Figure 4.7 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Payers Segment, 2016–2027
Figure 4.8 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Pharmaceutical Segment, 2016–2027
Figure 4.9 Global Digital Therapeutics Market Attractiveness Index, By End-User, 2017–2027
Figure 4.10 Global Digital Therapeutics Market, By Region, AGR Forecast 2017-2027 (AGR %)
Figure 4.11 Global Digital Therapeutics Market, By Region Segment Forecast 2017-2027 (US$Bn, Global AGR %)
Figure 4.12 Global Digital Therapeutics Market, Market Share Split & BPS Analysis, By Region Segment, 2017–2027
Figure 4.13 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By North America, 2016–2027
Figure 4.14 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Latin America, 2016–2027
Figure 4.15 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Europe, 2016–2027
Figure 4.16 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Asia Pacific, 2016–2027
Figure 4.17 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Middle East, 2016–2027
Figure 4.18 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Africa, 2016–2027
Figure 4.19 Global Digital Therapeutics Market Attractiveness Index, By Region, 2017–2027
Figure 4.20 Global Digital Therapeutics Market by Region Submarket Share Forecast 2017 (% Share)
Figure 4.21 Global Digital Therapeutics Market by Region Submarket Share Forecast 2022 (% Share)
Figure 4.22 Global Digital Therapeutics Market by Region Segment Submarket Share Forecast 2027 (% Share)
Figure 4.23 Global Digital Therapeutics Market Share by Countries Market Forecast 2017 (% Share)
Figure 4.24 Global Digital Therapeutics Market Share by Countries Market Forecast 2022 (% Share)
Figure 4.25 Global Digital Therapeutics Market Share by Countries Market Forecast 2027 (% Share)
Figure 5.1 Global Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By North America, 2016–2027
Figure 5.2 North America Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
Figure 5.3 North America Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, Global AGR %)
Figure 5.4 North America Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017–2027
Figure 5.5 North America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By the U.S., 2016–2027
Figure 5.6 North America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Canada, 2016–2027
Figure 5.7 North America Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
Figure 5.8 North America Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
Figure 5.9 North America Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
Figure 5.10 North America Digital Therapeutics Market Attractiveness Index, By Application, 2017–2027
Figure 5.11 North America Digital Therapeutics Market Attractiveness Index, By End-User, 2017–2027
Figure 5.12 North America Digital Therapeutics Market Attractiveness Index, By Country, 2017–2027
Figure 6.1 Latin America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%),2016–2027
Figure 6.2 Latin America Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
Figure 6.3 Latin America Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, Latin America AGR %)
Figure 6.4 Latin America Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017–2027
Figure 6.5 Latin America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Brazil, 2016–2027
Figure 6.6 Latin America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Mexico, 2016–2027
Figure 6.7 Latin America Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Rest of Latin America, 2016–2027
Figure 6.8 Latin America Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
Figure 6.9 Latin America Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
Figure 6.10 Latin America Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
Figure 6.11 Latin America Digital Therapeutics Market Attractiveness Index, By Application, 2017–2027
Figure 6.12 Latin America Digital Therapeutics Market Attractiveness Index, By End-User, 2017–2027
Figure 6.13 Latin America Digital Therapeutics Market Attractiveness Index, By Country, 2017–2027
Figure 7.1 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%),2016–2027
Figure 7.2 Europe Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
Figure 7.3 Europe Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, Europe AGR %)
Figure 7.4 Europe Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017–2027
Figure 7.5 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By U.K., 2016–2027
Figure 7.6 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By France, 2016–2027
Figure 7.7 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Germany, 2016–2027
Figure 7.8 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Italy, 2016–2027
Figure 7.9 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Spain, 2016–2027
Figure 7.10 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Russia, 2016–2027
Figure 7.11 Europe Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Rest of Europe, 2016–2027
Figure 7.12 Europe Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
Figure 7.13 Europe Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
Figure 7.14 Europe Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
Figure 7.15 Europe Digital Therapeutics Market Attractiveness Index, By Application, 2017–2027
Figure 7.16 Europe Digital Therapeutics Market Attractiveness Index, By End-User, 2017–2027
Figure 7.17 Europe Digital Therapeutics Market Attractiveness Index, By Country, 2017–2027
Figure 8.1 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%),2016–2027
Figure 8.2 Asia Pacific Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
Figure 8.3 Asia Pacific Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, Asia Pacific AGR %)
Figure 8.4 Asia Pacific Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017–2027
Figure 8.5 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By China, 2016–2027
Figure 8.6 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By India, 2016–2027
Figure 8.7 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Australia and New Zealand, 2016–2027
Figure 8.8 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Japan, 2016–2027
Figure 8.9 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By ASEAN, 2016–2027

Figure 8.10 South Korea Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By South Korea, 2016–2027
Figure 8.11 Asia Pacific Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Rest of Asia Pacific, 2016–2027
Figure 8.12 Asia Pacific Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
Figure 8.13 Asia Pacific Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
Figure 8.14 Asia Pacific Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
Figure 8.15 Asia Pacific Digital Therapeutics Market Attractiveness Index, By Application, 2017–2027
Figure 8.16 Asia Pacific Digital Therapeutics Market Attractiveness Index, By End-User, 2017–2027
Figure 8.17 Asia Pacific Digital Therapeutics Market Attractiveness Index, By Country, 2017–2027
Figure 9.1 Middle East Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%),2016–2027
Figure 9.2 Middle East Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
Figure 9.3 Middle East Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, AGR %)
Figure 9.4 Middle East Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017–2027
Figure 9.4 Middle East Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017–2027
Figure 9.5 Middle East Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By GCC, 2016–2027
Figure 9.6 Middle East Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By Israel, 2016–2027
Figure 9.7 Middle East Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
Figure 9.8 Middle East Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
Figure 9.9 Middle East Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
Figure 9.10 Middle East Digital Therapeutics Market Attractiveness Index, By Application, 2017–2027
Figure 9.11 Middle East Digital Therapeutics Market Attractiveness Index, By End-User, 2017–2027
Figure 9.12 Middle East Digital Therapeutics Market Attractiveness Index, By Country, 2017–2027
Figure 10.1 Middle East Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), 2016–2027
Figure 10.2 Middle East Digital Therapeutics Market, By Country, AGR Forecast 2017-2027 (AGR %)
Figure 10.3 Africa Digital Therapeutics Market, By Country Segment Forecast 2017-2027 (US$Bn, AGR %)
Figure 10.4 Middle East Digital Therapeutics Market, Market Share Split & BPS Analysis, By Country, 2017–2027
Figure 10.5 Africa Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By South Africa, 2016–2027
Figure 10.6 Africa Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By South Africa, 2016–2027
Figure 10.7 Africa Digital Therapeutics Market Value (US$ Bn) Forecast and AGR (%), By North Africa, 2016–2027
Figure 10.8 Africa Digital Therapeutics Market by Country Submarket Share Forecast 2017 (% Share)
Figure 10.9 Africa Digital Therapeutics Market by Country Submarket Share Forecast 2022 (% Share)
Figure 10.10 Middle East Digital Therapeutics Market by Country Submarket Share Forecast 2027 (% Share)
Figure 10.11 Africa Digital Therapeutics Market Attractiveness Index, By Application, 2017–2027
Figure 10.12 Africa Digital Therapeutics Market Attractiveness Index, By End-User, 2017–2027
Figure 10.13 Africa Digital Therapeutics Market Attractiveness Index, By Country, 2017–2027

List of Tables
Table 1.1 Digital Therapeutics Market by Regional Market Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 2.1 Global Digital Therapeutics Market Forecast 2017-2027 (US$m, AGR %, CAGR %, Cumulative)
Table 3.1 Global Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 3.2 Global Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
Table 3.3 Global Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 4.1 Global Digital Therapeutics Market, By End-User Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 4.2 Global Digital Therapeutics Market Forecast, By End-User Segment ($Bn, AGR%) 2016-2027
Table 4.3 Global Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 4.4 Global Digital Therapeutics Market, By Region Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 4.5 Global Digital Therapeutics Market Forecast, By Region Segment ($Bn, AGR%) 2016-2027
Table 4.6 Global Digital Therapeutics Market, By Region CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 4.7 Leading Digital Therapeutics Market by Region Forecast 2017-2027 (US$Bn, Global AGR %, Cumulative)
Table 4.7 Leading Digital Therapeutics Market by Region Forecast 2017-2027 (US$Bn, Global AGR %, Cumulative)
Table 5.1 North Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
Table 5.2 North America Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 5.3 North America Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 5.4 North America Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
Table 5.5 North America Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 5.6 North America Digital Therapeutics Market, By End-User Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 5.7 North America Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
Table 5.8 North America Digital Therapeutics Market, By End-User, CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 6.1 Latin America Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
Table 6.2 Latin America Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 6.3 Latin America Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 6.4 Latin America Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
Table 6.5 Latin America Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
Table 6.6 Latin America Digital Therapeutics Market Forecast, By End-User, Sub-Segment ($Bn, AGR%) 2016-2027
Table 6.7 Latin America Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 7.1 Europe Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
Table 7.2 Europe Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 7.3 Europe Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 7.4 Europe Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
Table 7.5 Europe Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 7.6 Europe Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
Table 7.7 Europe Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 8.1 Asia Pacific Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
Table 8.2 Asia Pacific Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 8.3 Asia Pacific Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 8.4 Asia Pacific Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 8.5 Asia Pacific Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
Table 8.6 Asia Pacific Digital Therapeutics Market Forecast, By End-User, Sub-Segment ($Bn, AGR%) 2016-2027
Table 8.7 Asia Pacific Digital Therapeutics Market by Patients End-User Sub-Segment Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 8.8 Asia Pacific Digital Therapeutics Market, By Caregivers End-User Sub-Segment Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 8.9 Asia Pacific Digital Therapeutics Market by End-User, Patients Sub-segment, 2016-2027
Table 8.10 Asia Pacific Digital Therapeutics Market, By End-User, Sub-Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 9.1 Middle East Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
Table 9.2 Middle East Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 9.3 Middle East Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 9.4 Middle East Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
Table 9.5 Middle East Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 9.6 Middle East Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
Table 9.7 Middle East Digital Therapeutics Market Forecast, By End-User, Sub-Segment ($Bn, AGR%) 2016-2027
Table 9.8 Middle East Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 10.1 Middle East Digital Therapeutics Market Forecast, ($Bn, AGR%) 2016-2027
Table 10.2 Africa Digital Therapeutics Market, By Country Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 10.3 Africa Digital Therapeutics Market, By Application Forecast 2017-2027 (US$Bn, AGR %, Cumulative)
Table 10.4 Africa Digital Therapeutics Market Forecast, By Application ($Bn, AGR%) 2016-2027
Table 10.5 Africa Digital Therapeutics Market, By Application Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 10.6 Africa Digital Therapeutics Market, By End-User Forecast 2016-2027 (US$Bn, AGR %, Cumulative)
Table 10.7 Africa Digital Therapeutics Market Forecast, By End-User Segment ($Bn, AGR%) 2016-2027
Table 10.8 Africa Digital Therapeutics Market, By End-User Segment CAGR Forecast 2017-2022, 2022-2027, 2017-2027 (CAGR %)
Table 11.1 Omada Health Profile 2016
Table 11.2 Omada Health Key Developments
Table 11.3 Canary Health Profile 2016
Table 11.4 Canary Health Key Developments
Table 11.5 Noom Inc. Profile 2016
Table 11.6 Noom Inc. Key Developments
Table 11.7 Livongo Health Profile 2016
Table 11.8 Livongo Health
Table 11.9 WellDoc Inc. Profile 2016
Table 11.10 WellDoc Inc. Key Developments
Table 11.11 Propeller Health Profile 2016
Table 11.12 Propeller Health Key Developments
Table 11.13 Evolent Health Profile 2016
Table 11.14 Evolent Health Total Company Sales 2015-2016 (US$mn AGR%)
Table 11.15 Evolent Health Financial Statement 2015-2016
Table 11.16 Doximity Profile 2016
Table 11.17 Doximity Key Developments
Table 11.18 Perfint Healthcare Profile 2016
Table 11.19 Proteus Digital Health Inc. Profile 2016
Table 11.20 Other Companies of Interest in the Digital Therapeutics Market
Table 11.20 Other Companies of Interest in the Digital Therapeutics Market

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ デジタル治療のの世界市場2017-2027(THE DIGITAL THERAPEUTICS MARKET FORECAST 2017-2027 : Forecasts by Application (Diabetes, Obesity CVD, CNS, Respiratory) End-User, (Patients, Caregivers, Employers, Payers, Pharmaceutical Companies) and Geography)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆